✦ LIBER ✦

Letter by Apostolakis et al Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R 2 CHADS 2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts”

✍ Scribed by Apostolakis, Stavros ;Lane, Deirdre A. ;Banerjee, Amitava

Book ID: 125536153
Publisher: Lippincott Williams and Wilkins
Year: 2013
Tongue: English
Weight: 419 KB
Volume: 128
Category: Article
ISSN: 0009-7322
DOI: 10.1161/CIRCULATIONAHA.112.000708

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intracranial Hemorrhage Among Patients W

Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban: The Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation

✍ Hankey, G. J.; Stevens, S. R.; Piccini, J. P.; Lokhnygina, Y.; Mahaffey, K. W.; 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 920 KB

Rivaroxaban—Once daily, oral, direct fac

Rivaroxaban—Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 242 KB